22 results
8-K/A
EX-99.1
PYXS
Pyxis Oncology Inc
27 Oct 23
Index to Consolidated Financial Statements
4:34pm
significant inputs derived from or corroborated by observable market data.
In certain cases where there is limited activity or less transparency around
8-K/A
EX-99.2
PYXS
Pyxis Oncology Inc
27 Oct 23
Index to Consolidated Financial Statements
4:34pm
activity or less transparency around the inputs to valuation, we classify securities as Level 3. Level 3 liabilities consist of derivative warrant
424B3
8cdw 0hjczc
30 Jun 23
Prospectus supplement
4:05pm
S-4/A
kq73w7f9vrng578 3se5
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
1s0 hr0v7r4xyyt
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
10-K
i4ap8 w3933j8o0xa
29 Mar 22
Annual report
7:36am
10-Q
8lmwp 1e7u1
15 Nov 21
Quarterly report
7:54am
424B4
8xgxn sh2
8 Oct 21
Prospectus supplement with pricing info
5:00pm
S-1
j3ogy27 ls
17 Sep 21
IPO registration
5:00pm
DRS/A
2ia9z 9n6tbis1gjh76
10 Sep 21
Draft registration statement (amended)
12:00am